Detalles de la búsqueda
1.
Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo.
Antimicrob Agents Chemother;
66(11): e0028422, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36314800
2.
The beneficial effect of fluoxetine on behavioral and cognitive changes in chronic experimental Chagas disease unveils the role of serotonin fueling astrocyte infection by Trypanosoma cruzi.
PLoS Negl Trop Dis;
18(5): e0012199, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38776344
3.
Sulfadiazine Plus Pyrimethamine Therapy Reversed Multiple Behavioral and Neurocognitive Changes in Long-Term Chronic Toxoplasmosis by Reducing Brain Cyst Load and Inflammation-Related Alterations.
Front Immunol;
13: 822567, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35572567
4.
Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.
PLoS One;
16(1): e0244710, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33400707
5.
Behavioral alterations in long-term Toxoplasma gondii infection of C57BL/6 mice are associated with neuroinflammation and disruption of the blood brain barrier.
PLoS One;
16(10): e0258199, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34610039
Resultados
1 -
5
de 5
1
Próxima >
>>